Review



p16 protein expression level  (CH Instruments)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CH Instruments p16 protein expression level
    Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
    P16 Protein Expression Level, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p16+protein+expression+level/p16+protein+expression+level/pmc10505467-135-0-5
    Average 90 stars, based on 1 article reviews
    p16 protein expression level - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma"

    Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

    Journal: Reports of Biochemistry & Molecular Biology

    doi: 10.52547/rbmb.12.1.83

    Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
    Figure Legend Snippet: Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.

    Techniques Used: Immunohistochemical staining, Staining

    Correlation between clinicopathological characteristics and p16 protein expression in women with invasive ductal breast carcinoma.
    Figure Legend Snippet: Correlation between clinicopathological characteristics and p16 protein expression in women with invasive ductal breast carcinoma.

    Techniques Used: Expressing

    Correlation of p16 expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.
    Figure Legend Snippet: Correlation of p16 expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.

    Techniques Used: Expressing

    Related Articles

    Expressing:

    Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma
    Article Snippet: .. Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD. ..



    Similar Products

    p16 protein expression level  (CH Instruments)
    90
    CH Instruments p16 protein expression level
    Immunohistochemical staining for <t>p16</t> protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.
    P16 Protein Expression Level, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p16+protein+expression+level/p16+protein+expression+level/pmc10505467-135-0-5
    Average 90 stars, based on 1 article reviews
    p16 protein expression level - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.

    Journal: Reports of Biochemistry & Molecular Biology

    Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

    doi: 10.52547/rbmb.12.1.83

    Figure Lengend Snippet: Immunohistochemical staining for p16 protein in invasive ductal breast tumors. A. p16 negative, B. p16 low positive, C. High-positive.

    Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

    Techniques: Immunohistochemical staining, Staining

    Correlation between clinicopathological characteristics and p16 protein expression in women with invasive ductal breast carcinoma.

    Journal: Reports of Biochemistry & Molecular Biology

    Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

    doi: 10.52547/rbmb.12.1.83

    Figure Lengend Snippet: Correlation between clinicopathological characteristics and p16 protein expression in women with invasive ductal breast carcinoma.

    Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

    Techniques: Expressing

    Correlation of p16 expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.

    Journal: Reports of Biochemistry & Molecular Biology

    Article Title: The Prognostic Significance of P16 Immunohistochemical Expression Pattern in Women with Invasive Ductal Breast Carcinoma

    doi: 10.52547/rbmb.12.1.83

    Figure Lengend Snippet: Correlation of p16 expression with tumor grade and age of patients with invasive ductal breast carcinoma. The data are shown as mean ± SD.

    Article Snippet: Parameters P16 Protein Expression Level P-value(Chi-Square) Negative (n = 29) Low-Positive (n = 44) High-Positive (n = 27) ER receptor Positive 22 (75.9%) 41 (93.2%) 17 (63%) 0.007* Negative 7 (24.1%) 3 (6.8%) 10 (37%) PR receptor Positive 14 (48.3%) 33 (75%) 16 (59.3%) 0.061 Negative 15 (51.7%) 11 (25%) 11 (40.7%) HER2 Positive 4 (13.8%) 15 (34.1%) 11 (40.7%) 0.065 Negative 25 (86.2%) 29 (65.9%) 16 (59.3%) Ki67 Positive (> 14%) 7 (24.1%) 16 (36.4%) 5 (18.5%) 0.229 Negative (≤ 14%) 22 (75.9%) 28 (63.6%) 22 (81.5%) Cancer Grade I 2 (6.9%) 2 (4.5%) 4 (14.8%) 0.252 II 20 (69%) 37 (84.1%) 17 (6%) III 7 (24.1%) 5 (11.4%) 6 (22.2%) Tumor Size ≤ 20 mm 11 (37.9%) 18 (40.9%) 13 (48.1%) 0.754 21-50 mm 18 (62.1%) 25 (56.8%) 14 (51.9%) > 50 mm 0 (0%) 1 (2.3%) 0 (0%) Cancer Type Luminal A 7 (29.16%) 13 (54.16%) 4 (16.66%) 0.144 Luminal B 15 (26.31%) 28 (49.12%) 14 (24.56%) HER2 positive 2 (28.57%) 1 (14.28%) 4 (57.14%) Triple Negative 5 (41.66%) 2 (16.66%) 5 (41.66%) Age ≤ 40 years 7 (24.1%) 11 (25%) 10 (37%) 0.471 > 40 yea 22 (75.9%) 33 (75%) 17 (63%) Family History Yes 5 (17.2%) 11 (25%) 5 (18.5%) 0.68 No 24 (82.8%) 33 (75%) 22 (81.5%) Open in a separate window The data are shown as mean ± SD.

    Techniques: Expressing